Product Code: ETC269529 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The UK radiotherapy market is expanding as the demand for effective cancer treatment options grows. Radiotherapy uses high-energy radiation to target and destroy cancer cells. The market benefits from advancements in radiotherapy technologies, increasing cancer incidence rates, and the integration of personalized medicine approaches in cancer treatment.
Expansion of the UK radiotherapy market is fueled by increasing cancer incidence rates, advancements in radiation therapy technologies, and personalized treatment approaches in oncology. Radiotherapy uses ionizing radiation to target and destroy cancer cells while minimizing damage to healthy tissues. Rising demand for intensity-modulated radiation therapy (IMRT), proton therapy, and stereotactic radiosurgery drives market growth. Technological innovations in image-guided radiotherapy (IGRT), adaptive treatment planning systems, and patient positioning devices support market expansion. Regulatory compliance with radiation safety guidelines, treatment efficacy standards, and healthcare reimbursement policies further stimulate market growth in the radiotherapy segment.
Challenges in the UK radiotherapy market include advancing radiation therapy technologies for cancer treatment, managing costs of radiotherapy equipment and treatment facilities, and ensuring access to radiotherapy services in remote and underserved regions.
In the UK, government policies in the radiotherapy market emphasize healthcare provision, patient access to cancer treatment, and technological advancement in radiation oncology. Regulations govern the safety, efficacy, and quality standards of radiotherapy equipment and treatment protocols used in cancer care facilities nationwide. The UK government supports initiatives that promote equitable access to radiotherapy services, enhance clinical outcomes through precision medicine approaches, and invest in infrastructure for advanced radiotherapy techniques. Additionally, policies aim to ensure workforce training and development in radiation oncology, foster research into innovative radiotherapy technologies, and address healthcare disparities in cancer treatment across regions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Radiotherapy Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Radiotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Radiotherapy Market - Industry Life Cycle |
3.4 United Kingdom (UK) Radiotherapy Market - Porter's Five Forces |
3.5 United Kingdom (UK) Radiotherapy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United Kingdom (UK) Radiotherapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Radiotherapy Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 United Kingdom (UK) Radiotherapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) Radiotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in the UK |
4.2.2 Technological advancements in radiotherapy equipment |
4.2.3 Growing awareness about the benefits of radiotherapy treatment |
4.3 Market Restraints |
4.3.1 High cost associated with radiotherapy equipment and treatment |
4.3.2 Limited access to radiotherapy services in certain regions of the UK |
4.3.3 Stringent regulations and approval processes for new radiotherapy technologies |
5 United Kingdom (UK) Radiotherapy Market Trends |
6 United Kingdom (UK) Radiotherapy Market, By Types |
6.1 United Kingdom (UK) Radiotherapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2021-2031F |
6.1.4 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Electron-emitting High-energy Linear Accelerators, 2021-2031F |
6.1.5 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Conventional Linear Accelerators, 2021-2031F |
6.1.6 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators, 2021-2031F |
6.1.7 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Conventional Cobalt-60 Teletherapy Units, 2021-2031F |
6.1.8 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Particle Therapy Systems, 2021-2031F |
6.1.9 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2021-2031F |
6.1.10 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2021-2031F |
6.2 United Kingdom (UK) Radiotherapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2021-2031F |
6.2.3 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Internal Beam Radiotherapy/Brachytherapy, 2021-2031F |
6.3 United Kingdom (UK) Radiotherapy Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2021-2031F |
6.3.3 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Internal Beam Radiotherapy/Brachytherapy, 2021-2031F |
6.3.4 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2021-2031F |
6.3.5 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Intravenous Radiotherapy, 2021-2031F |
6.3.6 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Oral Radiotherapy, 2021-2031F |
6.3.7 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Instillation Radiotherapy, 2021-2031F |
6.4 United Kingdom (UK) Radiotherapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.3 United Kingdom (UK) Radiotherapy Market Revenues & Volume, By Independent Radiotherapy Centers, 2021-2031F |
7 United Kingdom (UK) Radiotherapy Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Radiotherapy Market Export to Major Countries |
7.2 United Kingdom (UK) Radiotherapy Market Imports from Major Countries |
8 United Kingdom (UK) Radiotherapy Market Key Performance Indicators |
8.1 Average waiting time for radiotherapy treatment |
8.2 Utilization rate of radiotherapy facilities in the UK |
8.3 Number of clinical trials involving radiotherapy treatments in the UK |
9 United Kingdom (UK) Radiotherapy Market - Opportunity Assessment |
9.1 United Kingdom (UK) Radiotherapy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United Kingdom (UK) Radiotherapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Radiotherapy Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 United Kingdom (UK) Radiotherapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) Radiotherapy Market - Competitive Landscape |
10.1 United Kingdom (UK) Radiotherapy Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Radiotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |